Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: Mystery resolved?

Paulette Mhawech-Fauceglia, Kunle Odunsi, Daniel Dim, Norma Nowak, Shashikant Lele, Richard T. Cheney, Tanja Pejovic

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

High-grade neuroendocrine carcinomas (NECs) of the uterine corpus and ovary are very rare tumors, and whenever diagnosed, they are usually associated with epithelial carcinoma. Because of their rarity, the molecular characteristics of these tumors are still unknown. To shed some light, we studied the genetic abnormalities of each of the 2 components, NEC and adenocarcinoma, in 4 cases arising in the ovary and the uterine corpus using array-comparative genomic hybridization. Both components of all 4 cases showed almost similar genetic abnormalities. Genetic alterations exclusively seen in adenocarcinomas included losses of 2p21.1, 10q, 12q, 9p23, gains on 2p, 3p, 3q, 4p, 5q, 6q, 10p, 15q, and amplification of 6q22.31. However, the NEC component showed numerous additional genetic abnormalities in comparison with the adenocarcinomas including gain on 6p25.3-p21.2 and 19q12 and losses on 6q24.2-q27, 19q13.11-13.2, and 19q13.31-13.41, where numerous genes involved in the pathogenesis of epithelial ovarian carcinoma have been previously identified. Our data indicate that NEC and adenocarcinomas are, in most part, genetically similar tumors and might indeed have a common origin. However, the NEC components exhibited more genetic abnormalities in comparison with the adenocarcinoma, suggesting that when the NEC clones become more dedifferentiated, they acquire additional genetic abnormalities. Because of the limited cases analyzed, a larger study is still needed to confirm our observation.

Original languageEnglish (US)
Pages (from-to)539-546
Number of pages8
JournalInternational Journal of Gynecological Pathology
Volume27
Issue number4
DOIs
StatePublished - Oct 2008

Fingerprint

Neuroendocrine Carcinoma
Comparative Genomic Hybridization
Adenocarcinoma
Ovary
Carcinoma
Neoplasms
Clone Cells
Observation
Genes

Keywords

  • a-CGH
  • Adenocarcinoma
  • Gynecologic tract
  • Neuroendocrine carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma : Mystery resolved? / Mhawech-Fauceglia, Paulette; Odunsi, Kunle; Dim, Daniel; Nowak, Norma; Lele, Shashikant; Cheney, Richard T.; Pejovic, Tanja.

In: International Journal of Gynecological Pathology, Vol. 27, No. 4, 10.2008, p. 539-546.

Research output: Contribution to journalArticle

Mhawech-Fauceglia, Paulette ; Odunsi, Kunle ; Dim, Daniel ; Nowak, Norma ; Lele, Shashikant ; Cheney, Richard T. ; Pejovic, Tanja. / Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma : Mystery resolved?. In: International Journal of Gynecological Pathology. 2008 ; Vol. 27, No. 4. pp. 539-546.
@article{9e1edaddd1ab41b3841900147400218b,
title = "Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: Mystery resolved?",
abstract = "High-grade neuroendocrine carcinomas (NECs) of the uterine corpus and ovary are very rare tumors, and whenever diagnosed, they are usually associated with epithelial carcinoma. Because of their rarity, the molecular characteristics of these tumors are still unknown. To shed some light, we studied the genetic abnormalities of each of the 2 components, NEC and adenocarcinoma, in 4 cases arising in the ovary and the uterine corpus using array-comparative genomic hybridization. Both components of all 4 cases showed almost similar genetic abnormalities. Genetic alterations exclusively seen in adenocarcinomas included losses of 2p21.1, 10q, 12q, 9p23, gains on 2p, 3p, 3q, 4p, 5q, 6q, 10p, 15q, and amplification of 6q22.31. However, the NEC component showed numerous additional genetic abnormalities in comparison with the adenocarcinomas including gain on 6p25.3-p21.2 and 19q12 and losses on 6q24.2-q27, 19q13.11-13.2, and 19q13.31-13.41, where numerous genes involved in the pathogenesis of epithelial ovarian carcinoma have been previously identified. Our data indicate that NEC and adenocarcinomas are, in most part, genetically similar tumors and might indeed have a common origin. However, the NEC components exhibited more genetic abnormalities in comparison with the adenocarcinoma, suggesting that when the NEC clones become more dedifferentiated, they acquire additional genetic abnormalities. Because of the limited cases analyzed, a larger study is still needed to confirm our observation.",
keywords = "a-CGH, Adenocarcinoma, Gynecologic tract, Neuroendocrine carcinoma",
author = "Paulette Mhawech-Fauceglia and Kunle Odunsi and Daniel Dim and Norma Nowak and Shashikant Lele and Cheney, {Richard T.} and Tanja Pejovic",
year = "2008",
month = "10",
doi = "10.1097/PGP.0b013e31816bcda4",
language = "English (US)",
volume = "27",
pages = "539--546",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma

T2 - Mystery resolved?

AU - Mhawech-Fauceglia, Paulette

AU - Odunsi, Kunle

AU - Dim, Daniel

AU - Nowak, Norma

AU - Lele, Shashikant

AU - Cheney, Richard T.

AU - Pejovic, Tanja

PY - 2008/10

Y1 - 2008/10

N2 - High-grade neuroendocrine carcinomas (NECs) of the uterine corpus and ovary are very rare tumors, and whenever diagnosed, they are usually associated with epithelial carcinoma. Because of their rarity, the molecular characteristics of these tumors are still unknown. To shed some light, we studied the genetic abnormalities of each of the 2 components, NEC and adenocarcinoma, in 4 cases arising in the ovary and the uterine corpus using array-comparative genomic hybridization. Both components of all 4 cases showed almost similar genetic abnormalities. Genetic alterations exclusively seen in adenocarcinomas included losses of 2p21.1, 10q, 12q, 9p23, gains on 2p, 3p, 3q, 4p, 5q, 6q, 10p, 15q, and amplification of 6q22.31. However, the NEC component showed numerous additional genetic abnormalities in comparison with the adenocarcinomas including gain on 6p25.3-p21.2 and 19q12 and losses on 6q24.2-q27, 19q13.11-13.2, and 19q13.31-13.41, where numerous genes involved in the pathogenesis of epithelial ovarian carcinoma have been previously identified. Our data indicate that NEC and adenocarcinomas are, in most part, genetically similar tumors and might indeed have a common origin. However, the NEC components exhibited more genetic abnormalities in comparison with the adenocarcinoma, suggesting that when the NEC clones become more dedifferentiated, they acquire additional genetic abnormalities. Because of the limited cases analyzed, a larger study is still needed to confirm our observation.

AB - High-grade neuroendocrine carcinomas (NECs) of the uterine corpus and ovary are very rare tumors, and whenever diagnosed, they are usually associated with epithelial carcinoma. Because of their rarity, the molecular characteristics of these tumors are still unknown. To shed some light, we studied the genetic abnormalities of each of the 2 components, NEC and adenocarcinoma, in 4 cases arising in the ovary and the uterine corpus using array-comparative genomic hybridization. Both components of all 4 cases showed almost similar genetic abnormalities. Genetic alterations exclusively seen in adenocarcinomas included losses of 2p21.1, 10q, 12q, 9p23, gains on 2p, 3p, 3q, 4p, 5q, 6q, 10p, 15q, and amplification of 6q22.31. However, the NEC component showed numerous additional genetic abnormalities in comparison with the adenocarcinomas including gain on 6p25.3-p21.2 and 19q12 and losses on 6q24.2-q27, 19q13.11-13.2, and 19q13.31-13.41, where numerous genes involved in the pathogenesis of epithelial ovarian carcinoma have been previously identified. Our data indicate that NEC and adenocarcinomas are, in most part, genetically similar tumors and might indeed have a common origin. However, the NEC components exhibited more genetic abnormalities in comparison with the adenocarcinoma, suggesting that when the NEC clones become more dedifferentiated, they acquire additional genetic abnormalities. Because of the limited cases analyzed, a larger study is still needed to confirm our observation.

KW - a-CGH

KW - Adenocarcinoma

KW - Gynecologic tract

KW - Neuroendocrine carcinoma

UR - http://www.scopus.com/inward/record.url?scp=58149189087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149189087&partnerID=8YFLogxK

U2 - 10.1097/PGP.0b013e31816bcda4

DO - 10.1097/PGP.0b013e31816bcda4

M3 - Article

C2 - 18753966

AN - SCOPUS:58149189087

VL - 27

SP - 539

EP - 546

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 4

ER -